Optimal Medicine Inc. Renamed IXICO Technologies Inc.
Today IXICO plc is pleased to announce that Optimal Medicine Inc. has been renamed IXICO Technologies Inc. with immediate effect.
A key part of the Optimal Medicine acquisition on 8 December 2015 was to bring US infrastructure and IT Healthcare expertise. The renaming of the company to IXICO Technologies Inc is a final and important step in the integration of Optimal Medicine within the enlarged IXICO Group and reflects the Company’s plans to build the US presence under the leadership of Kenneth Tubman, who joined the Group management team as VP of Healthcare Technology.
The IXICO Technologies Inc. team are focused on developing and supporting IXICO’s mehealth® products and associated services in clinical decision support. They will:
- Play a key role in supporting the mehealth® for ADHD technology pilot with the American Academy of Pediatrics (“AAP”) as part of its Chapter Quality Network improvement program (see full press release here);
- Lead development of IXICO’s MyBrainBook® digital platform for patients with dementia as part of a number of NHS Testbed pilots (see full press release here); and
- Lead the expansion of the mehealth® product into monitoring patients with dementia and the incorporation of wearable sensor technologies as part of IXICO’s Cygnus study (see full press release here).